Testing effectiveness (Phase 2)Ended earlyNCT01540292
What this trial is testing
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
Who this might be right for
Crohn's Disease
University of Liege 13